title: Malignant fibrous histiocytoma of bone: a clinicopathologic study of 81 patients.
authors.forename: H J
authors.initials: HJ
authors.lastname: Hoekstra
authors.forename: S J
authors.initials: SJ
authors.lastname: Ham
authors.forename: W T
authors.initials: WT
authors.lastname: van der Graaf
authors.forename: W A
authors.initials: WA
authors.lastname: Kamps
authors.forename: W M
authors.initials: WM
authors.lastname: Molenaar
authors.forename: H
authors.initials: H
authors.lastname: Schraffordt Koops
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D018219:Histiocytoma, Benign Fibrous / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use*; D011379:Prognosis; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D008727:Methotrexate